Related Experiment Video
Updated: May 26, 2026
05:48
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Evaluating a virtual paediatric adverse drug reaction clinic
Emily Hauck1, Blanca Del Pozzo-Magana1, Michael Rieder1
1Division of Paediatric Clinical Pharmacology, Department of Paediatrics, University of Western Ontario, London, Ontario, Canada.
British Journal of Clinical Pharmacology
|May 24, 2026
Summary
A virtual pediatric adverse drug reaction (ADR) clinic successfully assessed 225 cases over three years, improving access to care for children, especially those in remote areas. Patient families and clinicians reported high satisfaction with the telemedicine approach.
Area of Science:
- Pediatric Pharmacology
- Clinical Toxicology
- Health Services Research
Background:
- Adverse drug reactions (ADRs) pose a significant challenge in pediatric healthcare.
- Limited access to specialized expertise for evaluating and managing pediatric ADRs leads to delays in care.
- The COVID-19 pandemic highlighted the need for innovative healthcare delivery models.
Purpose of the Study:
- To evaluate the real-world experience and patient/clinician satisfaction with a virtual pediatric ADR clinic.
- To assess the efficiency and effectiveness of telemedicine in managing pediatric ADRs.
Main Methods:
- Mixed-methods approach combining retrospective chart review and satisfaction surveys.
- Analysis of data from an online database for virtual ADR assessments.
- Surveys distributed to patient families and referring clinicians.
Main Results:
- Over three years, 225 pediatric ADRs were assessed virtually.
- High percentage of patients (43.6%) were from distant rural and urban locations, indicating improved access.
- High satisfaction rates reported: 95.0% for patient families and 93.3% for referring physicians.
- Successful allergy de-labeling demonstrated through diagnostic testing results.
Conclusions:
- The virtual pediatric ADR clinic demonstrated efficient real-world assessment and triage of children with suspected ADRs.
- Telemedicine presents a feasible solution to enhance access to specialized pediatric ADR services.
- Virtual clinics can overcome geographical barriers and improve the timeliness of care for pediatric ADRs.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...